ArticleVaccine2023

Anti-tumor necrosis factor therapy is associated with attenuated humoral response to SARS-COV-2 vaccines in patients with inflammatory bowel disease.

Filipa Bordalo Ferreira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.